Jj. Goldberger et al., UTILITY OF PREDISCHARGE AND ONE-MONTH TRANSVENOUS IMPLANTABLE DEFIBRILLATOR TESTS, The American journal of cardiology, 79(6), 1997, pp. 822
We evaluated the utility of performing predischarge implantable cardio
verter-defibrillator (ICD) testing and ICD testing at 1 month in detec
ting ICD-related problems, identifying 4 patients with an unacceptable
increase in defibrillation threshold. Given that ICD testing is nonin
vasive and has minimal (if any) associated risk, we recommend that pre
discharge and 1-month follow-up ICD testing should be performed after
implantation.